Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

15.77

+0.14 (0.90%)

Aug 14, 2025, 2:17 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dermatological Treatments	196.54M	Log In	Log In
Dermatological Treatments Growth	229.74%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States and Canada	196.54M	Log In	Log In
United States and Canada Growth	229.74%	Log In	Log In
United States	-	Log In	Log In